Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ology Bioservices and Rafa Laboratories announced they received full approval from the FDA for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector.
read more
Pharmaceutical Product Development (PPD) has named Ron Garrow executive vice president and chief human resource officer.
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
Purdue Pharma has announced leadership changes to the company’s Board of Directors and Executive Committee effective immediately.
read more
WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully.
read more
Pharmaceutical Product Development has expanded its central lab technology capabilities integrated with Preclarus.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Sinclair Research has named Scott E. Boley, PhD, DABT, as vice president of toxicology.
read more
Under the agreement granting the exclusive right to license the technology, Q BioMed will continue to evaluate the feasibility and usability of GDF15, a novel biomarker for monitoring glaucoma.
read more
As part of its ongoing implementation of the Drug Quality and Security Act and to advance the goals of its 2018 Compounding Policy Priorities Plan, the U.S. Food and Drug Administration is announcing several actions to protect public health related ...
read more
STA Pharmaceutical announces its API manufacturing facility at Jinshan has successfully passed its fourth inspection from the FDA – with no Form 483s issued.
read more
I-Mab Biopharma and ABL Bio, jointly announced that two companies had entered into a partnering agreement for ABL Bio to in-license the global rights excluding Greater China to I-Mab's bispecific antibodies of undisclosed target with licensing ...
read more
Linical and Accelovance recently merged to create a midsized, global contract research organization (CRO) with a footprint across North America, Europe and Asia-Pacific.
read more
Avid Bioservices announced the appointment of Daniel Hart as chief financial officer.
read more
PharmaMar announced the signing of an agreement with Impilo Pharma, a part of Immedica Group, for the exclusive promotion and distribution of its antitumour compound, Yondelis.
read more